BRIEF—HIV specialist seeks to raise $200 million in public offering

Washington state, USA-based CytoDyn has lodged a  regulatory filing for a mixed shelf offering, seeking to raise $200 million.

A shelf offering allows a firm to offer new securities to the public market incrementally, over a period of time.

The HIV specialist did not specify what it had in mind for the proceeds, stating only that it would be used for wide-ranging “general corporate purposes.”